Clinical Trials News for PV and ET Patients
Last week two companies reported news on their clinical trials for myeloproliferative neoplasms:
- AOP Orphan Pharmaceuticals announced that Phase III trials were going well for their study on Pegasys in PV patients. This study is being conducted in Europe and is currently recruiting.
- Promedior has initiated a new Phase II clinical trial for their compound, PRM-151, in people with myelofibrosis.
Ongoing clinical trials for PV, ET, and MF can be found at clinicaltrials.gov as well as the MPN Research Foundation's site. Participating in a clinical trial should be considered carefully and discussed with your physician and family.
About the Blog
Check back regularly for updates about what’s happening in the MPN community, from advocacy to research..